Class IIOngoing

Clindamycin HCl recall

FDA recall D-0378-2025 · initiated Mar 24, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations

Details

Product: Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00
Recalling company: RemedyRepack Inc.
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: PA
Initiated: Mar 24, 2025
FDA report date: Apr 30, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0378-2025 ↗

← All drug recalls